These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28339393)

  • 1. PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution.
    Rost E
    Int J Pharm Compd; 2016; 20(6):526-527. PubMed ID: 28339393
    [No Abstract]   [Full Text] [Related]  

  • 2. When to Compound Medications for Veterinary Patients.
    Forsythe LE
    Int J Pharm Compd; 2017; 21(1):19-21. PubMed ID: 28346193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding of Veterinary Drugs for Equine Practitioners.
    Stanley SD; Moffitt K; Wiebe V
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):213-225. PubMed ID: 28325180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting.
    Martinez M; Rathbone M; Burgess D; Huynh M
    J Control Release; 2008 Jul; 129(2):79-87. PubMed ID: 18514351
    [No Abstract]   [Full Text] [Related]  

  • 5. Compounding and Extralabel Use of Drugs in Exotic Animal Medicine.
    Powers LV; Davidson G
    Vet Clin North Am Exot Anim Pract; 2018 May; 21(2):195-214. PubMed ID: 29655467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounding Transdermal Medication for Feline Patients.
    Eichstadt LR
    Int J Pharm Compd; 2016; 20(4):271-274. PubMed ID: 28333671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding policies updated in anticipation of federal action.
    J Am Vet Med Assoc; 2013 Aug; 243(3):307-8. PubMed ID: 24024283
    [No Abstract]   [Full Text] [Related]  

  • 8. Veterinary compounding in small animals: a clinical pharmacologist's perspective.
    Boothe DM
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1129-73, viii. PubMed ID: 16984830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some compounding may be allowed, even if still illegal.
    J Am Vet Med Assoc; 2015 Jul; 247(1):25. PubMed ID: 26285314
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for compounding commercially available products.
    Murry T
    Am J Vet Res; 2009 Nov; 70(11):1307; author reply 1307-8. PubMed ID: 19878010
    [No Abstract]   [Full Text] [Related]  

  • 11. Consultation for Human, Veterinary, and Compounded Medications.
    Moghadam G; Forsythe LE
    Int J Pharm Compd; 2017; 21(2):111-115. PubMed ID: 28346205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA/CVM's Compliance Policy Guide on compounding of drugs.
    J Am Vet Med Assoc; 1996 Dec; 209(12):2025-9. PubMed ID: 8960175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biological functions of lipid excipients and the implications for pharmaceutical products development.
    Wasan KM
    J Pharm Sci; 2009 Feb; 98(2):379-82. PubMed ID: 18484625
    [No Abstract]   [Full Text] [Related]  

  • 15. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extralabel drug use and compounding in veterinary medicine.
    Geyer RE
    Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027
    [No Abstract]   [Full Text] [Related]  

  • 18. The compounding controversy: what veterinarians should know to protect themselves and their patients.
    Davidson G
    J Am Anim Hosp Assoc; 2003; 39(1):13-7. PubMed ID: 12549608
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA seeks to clear up confusion about compounding.
    J Am Vet Med Assoc; 2003 Oct; 223(8):1103, 1106. PubMed ID: 14584731
    [No Abstract]   [Full Text] [Related]  

  • 20. The future of veterinary compounding.
    Jordan DG
    Int J Pharm Compd; 2014; 18(5):438-9. PubMed ID: 25581940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.